We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Adicet Bio
ACET
$74.7M
| $89K | ﹤0.01% |
2,945
+41
| +1% | +$894 |
|
3227
Cartesian Therapeutics
RNAC
$268M
| $87.9K | ﹤0.01% |
4,251
+47
| +1% | +$1.4K |
|
3228
LanzaTech
LNZA
$69.8M
| $87.2K | ﹤0.01% |
173
+2
| +1% | +$880 |
|
3229
Open Text
OTEX
$6.04B
| $87.2K | ﹤0.01% |
2,075
-75
| -3% | -$2.81K |
|
3230
Prelude Therapeutics
PRLD
$390M
| $87.1K | ﹤0.01% |
20,403
-13,412
| -40% | -$40.8K |
|
|
SUBC
3231
DELISTED
SUBSEA 7 S A SPONSORED ADR
SUBC
| $86.8K | ﹤0.01% |
5,985
+235
| +4% | +$3.41K |
|
3232
BioXcel Therapeutics
BTAI
$27.8M
| $85.5K | ﹤0.01% |
1,812
+100
| +6% | +$5.56K |
|
3233
iShares MSCI Denmark ETF
EDEN
$206M
| $85.3K | ﹤0.01% |
761
-800
| -51% | -$82.6K |
|
3234
OppFi
OPFI
$803M
| $84K | ﹤0.01% |
16,399
-380
| -2% | -$1.21K |
|
3235
Cue Biopharma
CUE
$114M
| $83.8K | ﹤0.01% |
1,058
+11
| +1% | +$786 |
|
3236
PrimeEnergy Resources
PNRG
$298M
| $83.6K | ﹤0.01% |
786
-11
| -1% | -$1.17K |
|
3237
Transcontinental Realty Investors
TCI
$323M
| $82.8K | ﹤0.01% |
2,396
-39
| -2% | -$1.2K |
|
3238
Ecopetrol
EC
$34.5B
| $82.1K | ﹤0.01% |
6,889
+1,470
| +27% | +$17.8K |
|
|
CLPR
3239
Clipper Realty
CLPR
$46.2M
| $81.9K | ﹤0.01% |
15,175
-732
| -5% | -$3.67K |
|
|
LENZ
3240
LENZ Therapeutics
LENZ
$168M
| $81.7K | ﹤0.01% |
4,457
-359
| -7% | -$5.93K |
|
|
KWY
3241
Kingsway Corp
KWY
$293M
| $81.6K | ﹤0.01% |
9,719
+116
| +1% | +$878 |
|
|
DDI
3242
DoubleDown Interactive
DDI
$588M
| $81.4K | ﹤0.01% |
10,975
| – | – |
|
3243
Blue Ridge Bankshares
BRBS
$332M
| $81.1K | ﹤0.01% |
26,775
+366
| +1% | +$1.12K |
|
|
EVA
3244
DELISTED
Enviva Inc.
EVA
| $80.5K | ﹤0.01% |
80,863
+813
| +1% | +$2.26K |
|
|
MIXT
3245
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $80.3K | ﹤0.01% |
9,324
| – | – |
|
|
ILPT
3246
Industrial Logistics Properties Trust
ILPT
$586M
| $80K | ﹤0.01% |
17,012
+1,988
| +13% | +$6.45K |
|
3247
Telecom Argentina
TEO
$5.96B
| $79.6K | ﹤0.01% |
+11,136
| New | +$71.4K |
|
3248
SKYX Platforms
SKYX
$164M
| $78.4K | ﹤0.01% |
48,991
-1,291
| -3% | -$2.01K |
|
3249
NatWest
NWG
$76.4B
| $77.6K | ﹤0.01% |
13,776
-160
| -1% | -$850 |
|
|
AZUL
3250
DELISTED
Azul
AZUL
| $77.4K | ﹤0.01% |
7,990
-335
| -4% | -$3.05K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.